COMPANY

HighLife

Transcatheter mitral valve replacement for mitral regurgitation. From company website Source · Oct 20, 2026

Profile checked Oct 20, 2026

Raises and deals from press releases

Raise Undisclosed round · $80M (converted from EUR) · announced Sep 22, 2026 Company release ↗
Source quote
- Sep 22, 2026 · Company release ↗
  “Paris, France, September 22 – HighLife SAS, a MedTech company focused on transcatheter solutions for structural heart disease, today announced the successful completion of a $90+ Million (€80 Million) financing round”

From the company’s own releases; this list is partial. All raises and deals